.jpg)
About this webinar
Assay miniaturisation is no longer just a nice-to-have, it’s the reality for many labs today. Whether it’s limited samples, rising reagent costs, or pressure to generate more data faster, researchers are being asked to stretch resources without compromising results.
In this talk, we’ll look at how SPT Labtech’s mosquito liquid handlers are helping labs tackle those pressures head-on, by enabling reliable, low-volume workflows that are both efficient and scalable. We’ll cover how mosquito is being used in a wide range of applications: from miniaturized NGS and single-cell omics to compound screening to nanoscale chemistry.
Through real examples from academic and industry labs, you’ll see how shifting to lower volumes isn’t just about saving money. It’s often what makes certain experiments feasible at all. Whether you're new to automation or already thinking in 1536-well format, you’ll leave with practical ideas for making your workflows more efficient, reproducible, and future-ready.
Key takeaways
- How to adapt existing genomics, screening, or chemistry workflows to nanolitre-scale volumes, including practical considerations.
- Where miniaturisation adds value beyond cost savings, such as enabling direct-from-cell protocols, parallel reaction optimisation, or working with ultra-low input samples.
- What successful implementation looks like in real labs, through case studies showing how academic and industry groups have scaled their work with mosquito.
To register for the webinar, complete the form on the left.
Meet the speakers
Kamila Koprowska, PhD
Kamila Koprowska is a product manager at SPT Labtech, specialising in miniaturisation and automation of assays for life sciences. She earned her PhD in 2012 from the Medical University of Lodz, where she studied apoptosis mechanisms in melanoma cells, and completed post-doctoral research at the University of Oxford, gaining hands-on experience in 3D cell culture and single-cell genomics. Kamila now collaborates closely with researchers across academic, biotech, and pharmaceutical sectors to understand their challenges in omics, early drug discovery, and nanoscale chemistry, with the goal of developing tools and approaches that enable cost-effective, scalable experiments.